Back
Sutro Biopharma 10K Form
Sell
22
STRO
Sutro Biopharma
Last Price:
$1.94
Seasonality Move:
-13.05%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-06 | 10Q | STRO/Sutro Biopharma Quarterly |
| 2020-05-11 | 10Q | STRO/Sutro Biopharma Quarterly |
| 2020-05-04 | 10K | STRO/Sutro Biopharma Annual |
| 2020-03-16 | 10K | STRO/Sutro Biopharma Annual |
| 2019-11-08 | 10Q | STRO/Sutro Biopharma Quarterly |
| 2019-08-14 | 10Q | STRO/Sutro Biopharma Quarterly |
Receive STRO News And Ratings
See the #1 stock for the next 7 days that we like better than STRO
STRO Financial Statistics
Sales & Book Value
| Annual Sales: | $153.7M |
|---|---|
| Cash Flow: | $-65.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.35 |
| Price / Book: | 1.36 |
Profitability
| EPS (TTM): | -1.61000 |
|---|---|
| Net Income (TTM): | $-124M |
| Gross Margin: | -- |
| Return on Equity: | -99.41% |
| Return on Assets: | -27.59% |
Sutro Biopharma Earnings Forecast
Key Sutro Biopharma Financial Ratios
-
The Research & Development expenses have been 117.36% of Revenue.
-
The Interest Expense is -22.24% of Operating Income.
-
The Net Earning history of STRO is -69.47% of Total Revenues.
-
Per Share Earnings over the last 8 years have been positive in 3 years.
Sutro Biopharma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | STRO |
| CUSIP: | 869367 |
| Website: | sutrobio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 3.09 |
| Quick Ratio: | 3.01 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
STRO Technical Analysis vs Fundamental Analysis
Sell
22
Sutro Biopharma (STRO)
is a Sell
Is Sutro Biopharma a Buy or a Sell?
-
Sutro Biopharma stock is rated a SellThe current Sutro Biopharma [STRO] share price is $1.84. The Score for STRO is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.